Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

THE GEORGE INSTITUTE

🇮🇳India

Country: 🇮🇳India

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Plasma-Lyte 148® versUs Saline Study

Phase 4

Completed

Conditions: Hypovolemia

Interventions: Drug: Plasma-Lyte 148®
Drug: 0.9% sodium chloride

First Posted Date: 2016-03-29

Last Posted Date: 2023-08-08

Lead Sponsor: The George Institute

Target Recruit Count: 5037

Registration Number: NCT02721654

Locations: 🇦🇺
Blacktown Hospital, Blacktown, New South Wales, Australia
🇦🇺
Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia
🇦🇺
The Sutherland Hospital, Caringbah, New South Wales, Australia

and more 48 locations

Triple Therapy Prevention of Recurrent Intracerebral Disease EveNts Trial

Phase 3

Recruiting

Conditions: Intracerebral Haemorrhage (ICH)
Hypertension

Interventions: Drug: telmisartan 20mg, amlodipine 2.5mg, and indapamide 1.25mg
Drug: Placebo

First Posted Date: 2016-03-04

Last Posted Date: 2024-04-22

Lead Sponsor: The George Institute

Target Recruit Count: 1600

Registration Number: NCT02699645

Locations: 🇦🇺
Liverpool Hospital, Liverpool, New South Wales, Australia
🇦🇺
Port Macquarie Base Hospital, Port Macquarie, New South Wales, Australia
🇦🇺
Royal Prince Alfred Hospital, Sydney, New South Wales, Australia

and more 62 locations

Selective Decontamination of the Digestive Tract in Intensive Care Unit Patients

Phase 3

Completed

Conditions: Septic Shock
Ventilator Associated Pneumonia
Sepsis
Critical Illness

Interventions: Drug: SDD Oral Paste
Drug: SDD Gastric Suspension
Drug: Intravenous Antibiotic

First Posted Date: 2015-03-17

Last Posted Date: 2023-08-14

Lead Sponsor: The George Institute

Target Recruit Count: 20010

Registration Number: NCT02389036

Locations: 🇦🇺
The George Institute for Global Health, Sydney, New South Wales, Australia
🇨🇦
Sunnybrook Health Sciences Centre, Toronto, Canada
🇬🇧
Imperial College London, London, United Kingdom

A Trial to Determine the Effects of a Behavioural Communication Strategy on Salt Levels in Foods

Not Applicable

Completed

Conditions: Reducing Salt in the Food Supply

Interventions: Other: Advocacy

First Posted Date: 2015-02-27

Last Posted Date: 2017-05-04

Lead Sponsor: The George Institute

Target Recruit Count: 45

Registration Number: NCT02373423

Theophylline and Steroids in Chronic Obstructive Pulmonary Disease (COPD) Study

Phase 4

Completed

Conditions: Chronic Obstructive Pulmonary Disease

Interventions: Drug: Placebo (for prednisone)
Drug: Theophylline
Drug: Placebo (for Theophylline)
Drug: Prednisone

First Posted Date: 2014-10-10

Last Posted Date: 2021-08-12

Lead Sponsor: The George Institute

Target Recruit Count: 1670

Registration Number: NCT02261727

Locations: 🇦🇺
The George Institute for Global Health, Sydney, New South Wales, Australia

Head Position in Stroke Trial (HeadPoST)

Not Applicable

Completed

Conditions: Intracerebral Haemorrhage
Ischemic Stroke

Interventions: Other: The lying flat (0°) head position for 24 hours
Other: The sitting-up (≥30°) head position for 24 hours

First Posted Date: 2014-06-12

Last Posted Date: 2017-02-09

Lead Sponsor: The George Institute

Target Recruit Count: 11096

Registration Number: NCT02162017

Locations: 🇦🇺
The George Institute for Global Health, Sydney, New South Wales, Australia

Changing Population Salt Consumption in Lithgow, Australia

Not Applicable

Completed

Conditions: Hypertension
Cardiovascular Disease
Blood Pressure

Interventions: Behavioral: Community-based salt reduction

First Posted Date: 2014-04-07

Last Posted Date: 2014-11-18

Lead Sponsor: The George Institute

Target Recruit Count: 991

Registration Number: NCT02105727

Locations: 🇦🇺
The George Institute for Global Health, Camperdown, New South Wales, Australia

China Salt Substitute and Stroke Study

Not Applicable

Completed

Conditions: Stroke

Interventions: Behavioral: Dietary sodium reduction

First Posted Date: 2014-03-19

Last Posted Date: 2021-04-08

Lead Sponsor: The George Institute

Target Recruit Count: 20996

Registration Number: NCT02092090

Locations: 🇨🇳
Hebei Province Centre for Disease Control and Prevention, Shijiazhuang, Hebei, China
🇨🇳
China Medical Universtity, Shenyang, Liaoning, China
🇨🇳
Ningxia Medical University, Yinchuan, Ningxia, China

and more 2 locations

Therapeutic Evaluation of Steroids in IgA Nephropathy Global Study (TESTING Low Dose Study)

Not Applicable

Completed

Conditions: IgA Glomerulonephritis

Interventions: Drug: Placebo
Drug: methylprednisolone

First Posted Date: 2012-03-21

Last Posted Date: 2021-09-23

Lead Sponsor: The George Institute

Target Recruit Count: 503

Registration Number: NCT01560052

Locations: 🇦🇺
Concord Repatriation and General Hospital, Concord, New South Wales, Australia
🇦🇺
Nepean Hospital, Kingswood, New South Wales, Australia
🇦🇺
Royal North Shore Hospital, St Leonards, New South Wales, Australia

and more 63 locations

ADjunctive coRticosteroid trEatment iN criticAlly ilL Patients With Septic Shock

Phase 4

Completed

Conditions: Septic Shock

Interventions: Drug: Sterile air filled vial
Drug: Hydrocortisone

First Posted Date: 2011-10-07

Last Posted Date: 2017-12-12

Lead Sponsor: The George Institute

Target Recruit Count: 3800

Registration Number: NCT01448109

Locations: 🇦🇺
Blacktown Hospital, Blacktown, New South Wales, Australia
🇦🇺
Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia
🇦🇺
St Vincent's Hospital, Darlinghurst, New South Wales, Australia

and more 67 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy